Court Opinion

ID: 4462628
Source: CourtListenerOpinion
Date Created: 2019-12-10 01:00:18.309743+00
Date Added: 2024-06-11T14:25:32.198201
License: Public Domain

Case: 19-20389      Document: 00515229351         Page: 1    Date Filed: 12/09/2019

           IN THE UNITED STATES COURT OF APPEALS
                    FOR THE FIFTH CIRCUIT
                                                                       United States Court of Appeals
                                                                                Fifth Circuit

                                    No. 19-20389
                                                                              FILED
                                                                       December 9, 2019
                                  Summary Calendar
                                                                         Lyle W. Cayce
                                                                              Clerk
VAL D. EMERY; BETTY A. EMERY,

              Plaintiffs–Appellants,

v.

MEDTRONIC, INCORPORATED; MEDTRONIC USA, INCORPORATED;
MEDTRONIC LOGISTIC, L.L.C.; COVIDIEN, L.P.; COVIDIEN HOLDING,
INCORPORATED; COVIDIEN SALES, L.L.C.,

              Defendants–Appellees.

                   Appeal from the United States District Court
                        for the Southern District of Texas
                              USDC No. 4:18-CV-358

Before OWEN, Chief Judge, and SOUTHWICK and WILLETT, Circuit Judges.
PER CURIAM:*
       Val D. Emery and Betty A. Emery appeal the summary judgment in
favor of Medtronic, Inc., the district court’s denial of their motion to compel
discovery, and the district court’s denial of their motion for extension of time
to respond to the summary judgment motion. We affirm.

       * Pursuant to 5TH CIR. R. 47.5, the court has determined that this opinion should not
be published and is not precedent except under the limited circumstances set forth in 5TH
CIR. R. 47.5.4.
    Case: 19-20389     Document: 00515229351     Page: 2   Date Filed: 12/09/2019

                                  No. 19-20389
                                        I
      Val Emery underwent two hernia repair surgeries, one in 2013 and one
in 2017. During Emery’s first surgery, Dr. Buckminster Farrow implanted a
ParietexTM Composite (PCO) mesh into the upper-left quadrant of Emery’s
abdomen. The PCO mesh is a prescription surgical-mesh medical device made
of polyester, manufactured by Covidien (now known as Medtronic). Dr. Farrow
testified that he implanted the mesh so that a portion of it extended past the
midline in the upper part of Emery’s abdomen. Dr. Zhen Fan performed
Emery’s second hernia repair surgery. Both Dr. Farrow and Dr. Fan stated in
their depositions that the second hernia was located in a different part of the
abdomen than the first hernia. During the second surgery, which was on the
midline area of Emery’s abdomen, Dr. Fan found old mesh. His operative notes
state that the mesh “had migrated [] mostly to the left side of the abdominal
wall.” However, Dr. Fan later stated in his deposition that “[i]f this is the mesh
from Dr. Farrow’s repair, it did not migrate.” Both Dr. Farrow and Dr. Fan
testified that they did not believe Medtronic’s mesh was defective.
      Emery sued Medtronic in the District Court of Harris County, Texas,
alleging manufacturing, design, and marketing defect claims, on both strict
liability and negligence theories. Emery asserted a res ipsa loquitur claim in
the alternative. Emery’s wife Betty also brought derivative claims related to
his alleged injuries. Emery served written discovery requests on Medtronic, to
which Medtronic responded, save for the request for production of documents.
Medtronic stated that it had responsive documents to produce, but due to their
confidential nature, it could not produce them without entry of a protective
order. Neither party secured such an order, and Medtronic did not produce the
documents. Medtronic later removed the case to the United States District
Court for the Southern District of Texas. In the federal district court, Emery
alleged that the PCO mesh implanted by Dr. Farrow was “defectively designed
                                        2
     Case: 19-20389      Document: 00515229351         Page: 3    Date Filed: 12/09/2019

                                      No. 19-20389
because it was made out of polyester, which was soft and flimsy, and had
unsealed edges.” Emery alleged that this design defect caused him to re-
herniate. Emery also alleged marketing defect claims and alternative counts
for res ipsa loquitur and circumstantial evidence of defect.
       After the deadline for Emery to designate experts had passed without
Emery having designated any, Medtronic moved for summary judgment. The
district court then granted a pending motion to dismiss filed by Medtronic on
Emery’s res ipsa loquitur and marketing defect claims. Emery does not appeal
these dismissals.      Emery responded to Medtronic’s motion for summary
judgement and simultaneously moved to extend the deadline to respond to the
motion. The district court decided that it would consider Medtronic’s motion
for summary judgment before ruling on Emery’s motion for extension. Mere
hours before the summary judgment hearing, Emery filed a motion to compel
with respect to the discovery requests that had been served on Medtronic more
than twenty-one months before in state court. The district court granted
Medtronic’s motion for summary judgment as to the design defect claim and
dismissed all of Emery’s remaining claims. It declined to grant Emery’s motion
for extension of time and denied as moot his motion to compel. Emery appeals
the summary judgment in favor of Medtronic and the order denying his motion
to compel and motion for extension.
                                            II
       We review a district court’s grant of summary judgment de novo. 1 We
apply the same standards as the district court, granting summary judgment
“if the movant shows that there is no genuine dispute as to any material fact
and the movant is entitled to judgment as a matter of law.” 2 We view the

       1 Bluebonnet Hotel Ventures, L.L.C. v. Wells Fargo Bank, N.A., 754 F.3d 272, 275 (5th
Cir. 2014) (citing DePree v. Saunders, 588 F.3d 282, 286 (5th Cir. 2009)).
       2 FED. R. CIV. P. 56(a).

                                             3
     Case: 19-20389       Document: 00515229351         Page: 4    Date Filed: 12/09/2019

                                      No. 19-20389
evidence in the light most favorable to the non-moving party and avoid
credibility determinations and weighing of the evidence. 3 Summary judgment
is mandated “against a party who fails to make a showing sufficient to
establish the existence of an element essential to that party’s case, and on
which that party will bear the burden of proof at trial.” 4 In that case, there is
no dispute as to a material fact “since a complete failure of proof concerning an
essential element of the nonmoving party’s case necessarily renders all other
facts immaterial.” 5
       To prove a design defect under Texas law, “a plaintiff must prove that
(1) the product was defectively designed so as to render it unreasonably
dangerous; (2) a safer alternative design existed; and (3) the defect was a
producing cause of the injury for which the plaintiff seeks recovery.” 6 We need
not address the first two elements here because Emery has failed to make a
sufficient showing on the third element. To be a producing cause, “(1) the cause
must be a substantial cause of the event in issue and (2) it must be a but-for
cause, namely one without which the event would not have occurred.” 7 Emery
has failed to produce any evidence that would allow a factfinder to determine
that the alleged defect in the mesh was the cause of his injury—the second
hernia. Emery claims that the defect in the mesh caused a recurrence of the
original hernia, but both doctors that operated on him testified in their
depositions that the second hernia was in a different location from the first.
Emery has produced no evidence to explain how the defect in the mesh caused

       3 Sandstad v. CB Richard Ellis, Inc., 309 F.3d 893, 896 (5th Cir. 2002) (citing Reeves
v. Sanderson Plumbing Prods. Inc., 530 U.S. 133, 150 (2000)).
       4 Celotex Corp. v. Catrett, 477 U.S. 317, 322 (1986).
       5 Id. at 322-23.
       6 Goodner v. Hyundai Motor Co., 650 F.3d 1034, 1040 (5th Cir. 2011) (quoting

Timpte Indus., Inc. v. Gish, 286 S.W.3d 306, 311 (Tex. 2009)).
       7 Ford Motor Co. v. Ledesma, 242 S.W.3d 32, 46 (Tex. 2007).

                                             4
     Case: 19-20389       Document: 00515229351          Page: 5     Date Filed: 12/09/2019

                                       No. 19-20389
a second hernia in a different location, nor would he be able to do so at trial
without expert testimony. “Under Texas law, expert testimony is generally
encouraged if not required to establish a products liability claim. In particular,
expert testimony is crucial in establishing that the alleged design defect caused
the injury.” 8 A factfinder cannot determine the cause of a hernia through lay
testimony alone. “Lay testimony is adequate to prove causation in those cases
in which general experience and common sense will enable a layman to
determine, with reasonable probability, the causal relationship between the
event and the condition.” 9 This is not one of those cases. We agree with the
district court that “medical malpractice and product liability cases are
quintessentially expert cases.” Because Emery failed to designate any experts,
he will be unable to bear the burden of proof at trial. Summary judgment was
thus appropriate.
                                             III
       Emery also claims that the district court erred in denying his motion to
compel discovery and in failing to grant him an extension of time for additional
discovery in order to oppose the motion for summary judgment. “We review a
district court’s discovery decisions for abuse of discretion and will affirm such
decisions unless they are arbitrary or clearly unreasonable.” 10 The district
court did not abuse its discretion. Emery did not move to compel discovery
until the morning of the summary judgment hearing after the case had been
in federal court for over a year. Emery has no explanation for this delay. It
was not arbitrary or clearly unreasonable for the district court to deny the

       8 Sims v. Kia Motors of Am., Inc., 839 F.3d 393, 409 (5th Cir. 2016) (internal quotation
marks omitted).
       9 Morgan v. Compugraphic Corp., 675 S.W.2d 729, 733 (Tex. 1984) (citing Lenger v.

Physician’s Gen. Hosp., Inc., 455 S.W.2d 703, 706 (Tex. 1970)).
       10 Moore v. Willis Indep. Sch. Dist., 233 F.3d 871, 876 (5th Cir. 2000) (citing Krim v.

BancTexas Group, Inc., 989 F.2d 1435, 1441-42 (5th Cir. 1993)).
                                              5
    Case: 19-20389         Document: 00515229351            Page: 6   Date Filed: 12/09/2019

                                        No. 19-20389
motion to compel under these circumstances. 11 Nor was it arbitrary or clearly
unreasonable for the district court to deny Emery more time to conduct
discovery before ruling on the motion for summary judgment. Rule 56(d)
requires the nonmovant to show “specified reasons [that] it cannot present
facts essential to justify its opposition” before the court can defer considering
the motion. 12 Emery showed no such reasons.                    It is immaterial that the
discovery period had not closed before the district court ruled on Medtronic’s
motion for summary judgment. The deadline for Emery to designate experts
had passed, and Emery’s design defect claim could not survive summary
judgment without expert testimony.
                                       *       *        *
Accordingly, the judgment of the district court is AFFIRMED.

      11   See Curry v. Strain, 262 F. App’x 650, 652 (5th Cir. 2008).
      12   FED. R. CIV. P. 56(d).
                                               6